May 14, 2015Posted on
0Comments

Dietary Intake of Lycopene Associated with Reduced Pancreatic Cancer Risk

Nutrition and Cancer Dietary Intake of Lycopene Is Associated with Reduced Pancreatic Cancer Risk1 Andre⁄ Nkondjock,*† Parviz Ghadirian,* **2 Kenneth C. Johnson,‡ Daniel Krewski,† and the Canadian Cancer Registries Epidemiology Research Group *Epidemiology Research Unit, Research Centre, Centre hospitalier de l\’Universite⁄ de Montre⁄ al (CHUM)-Hoˆ tel- Dieu; †McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, Universityof Ottawa, Ottawa, ON, Canada; **Department of Nutrition, Faculty of Medicine, University of Montreal, Montreal, QC, Canada; and ‡Surveillance and Risk Assessment Division, Centre for Chronic Disease Prevention and Control, Population and Public Health Branch, Health Canada, Ottawa, Canada ABSTRACT Although fruits and vegetables have been implicated in the etiology of pancreatic cancer, the role of phytochemicals in these food groups has received little attention to date. In this study, we investigated the possible association between dietary carotenoids and pancreatic cancer risk. A case-control study of 462 histologically confirmed pancreatic cancer cases and 4721 population-based controls in 8 Canadian provinces took place between 1994 and 1997. Dietary intake was assessed by a self-administered FFQ. Unconditional logistic regression was used to assess associations between specific and total carotenoid intakes and the risk of pancreatic cancer. All tests of statistical significance were 2-sided. After adjustment for age, province, BMI, smoking, educational attainment, dietary folate, and total energy intake, lycopene, provided mainly by tomatoes, was associated with a 31% reduction in pancreatic cancer risk among men [odds ratio (OR) _ 0.69; 95% CI: 0.46-0.96; P _ 0.026 for trend] when comparing the highest and lowest quartiles of intake. Both _-carotene (OR _ 0.57; 95% CI: 0.32-0.99; P _ 0.016 for trend) and total carotenoids (OR _ 0.58; 95% CI: 0.34-1.00; P _ 0.02 for trend) were associated with a significantly reduced risk among those who never smoked. The results of this study suggest that a diet rich in tomatoes and tomato-based products with high lycopene content may help reduce pancreatic cancer risk. J. Nutr. 135: 592-597, 2005. KEY WORDS: • pancreatic cancer • diet • carotenoids • lycopene • cancer prevention

Pancreatic cancer is the 4th leading cause of cancer-related deaths in both men and women in Canada (1). Survival is extremely low worldwide, with a 5-y survival rate of _5% (2), and a case fatality proportion of 99% within 12 mo of diagnosis (3). Several epidemiologic studies suggested that high consumption of fruits and vegetables, which are major sources of carotenoids, may play a role in the prevention of pancreatic cancer. Substantial evidence from experimental investigations showed that carotenoids precipitate cancer-preventing events, including antioxidant activity, enhancement of immune function, stimulation of gap junctional intercellular communication, induction of detoxifying enzymes, and inhibition of cellular proliferation (4,5). It was suggested that _-carotene suppresses cytochrome P450 1A1, an activator of procarcinogens (6). _-Carotene may control growth-inhibitory and proapoptotic effects in cancer cells through the redox regulation of the nuclear transcription factor NF-_B activity (7). Lycopene is the most efficient singlet oxygen quencher in vitro (8); lutein and zeaxanthin are scavengers of radical oxygen species (4), whereas _-cryptoxanthin may stimulate the expression of RB, an anti-oncogene and p73, a p53-related gene (9). Despite the mechanistic hypotheses suggesting that intake of carotenoids may be related to reduced pancreatic cancer risk, no epidemiologic studies have addressed this issue to date. The present case-control study was undertaken to investigate the possible association between the intake of specific and total carotenoids and pancreatic cancer risk within the Canadian National Enhanced Cancer Surveillance System (NECSS).3 This study also examined the modifying effect of smoking on the association between dietary carotenoid intake and pancreatic cancer risk because free radicals in cigarette smoke can alter the concentrations of most carotenoids (10). 1 Funded with the support of the Canadian Cancer Society through an award (A.N.) from the National Cancer Institute of Canada, the Natural Sciences and Engineering Research Council of Canada, the Social Sciences and Engineering Research Council of Canada, the McLaughlin Foundation, and Health Canada. This project used data collected through the National Enhanced Cancer Surveillance System, a collaboration of the Surveillance and Risk Assessment Division, Centre for Chronic Disease Prevention and Control, Population and Public Health Branch, Health Canada and the Canadian Cancer Registries Epidemiology Research Group.

2 To whom correspondence should be addressed. E-mail: parviz.ghadirian@umontreal.ca. 3 Abbreviations used: NECSS, National Enhanced Cancer Surveillance System; OR, odds ratio; USDA-NCC, USDA-Nutrition Coordinating Center. 0022-3166/05 $8.00 © 2005 American Society for Nutritional Sciences. Manuscript received 4 November 2004. Initial review completed 22 November 2004. Revision accepted 29 November 2004.

592 SUBJECTS AND METHODS Study population. The NECSS is a multisite, population-based, case-control study involving 21,020 participants with 1 of 19 types of cancer identified through cancer registries in 8 of the 10 Canadian provinces, namely, Alberta, British Columbia, Manitoba, Newfoundland, Nova Scotia, Ontario, Prince Edward Island, and Saskatchewan. The present investigation includes only pancreatic cancer cases, and is restricted to data obtained from direct interviews. The study population was described in detail elsewhere (11). Briefly, between April 1, 1994 and December 31, 1997, participating provincial registries identified pancreatic cancer cases as early as possible in the registration process to minimize the loss of subjects because pancreatic cancer is a rapidly fatal disease. All pancreatic cancer cases included in the NECSS were confirmed histologically, and defined according to the WHO\’s International Classification of Diseases, rubric 157 (12). Like most other studies of pancreatic cancer that collected information directly from case subjects, the overall proportion of eligible cases that responded was low. Among men diagnosed with pancreatic cancer, 30% had died before an interview could be conducted, and consent was not granted by physicians for an additional 15%. For women, 28% had died before they could be contacted, and the attending physician refused consent to approach patients for an additional 16%. The vast majority of cases were ascertained within 1-3 mo of diagnosis; physician consent to send questionnaires to patients was generally obtained within 1 mo, and _70% of questionnaires were returned within 2 mo of mailing. Response rates of eligible cases were 55% for men and 56% for women. The NECSS used frequency matching in selecting the control population to achieve age and gender distributions similar to those of all cancer cases combined. Based on the projected number of incident cancer cases by province, the questionnaires were mailed to 8117 subjects during the 1996 calendar year using the same protocol as for cases. Questionnaires were not returned for 573 controls (7.4%) because of incorrect or changed addresses. Strategies for control selection varied by province, depending on data accessibility. In Prince Edward Island, Nova Scotia, Manitoba, Saskatchewan, and British Columbia, provincial health insurance plans were tapped to obtain a random sample of the provincial population stratified by age and gender. In each of these provinces, _95% of residents are covered by public health care plans. Active military personnel and their families as well as indigenous peoples were excluded because they were covered by other plans. In Ontario, Ministry of Finance data were used to derive a stratified random sample, whereas Newfoundland and Alberta adopted a random digit-dialing method to enroll a population-based sample of controls. A total of 5039 controls were selected to serve as a common control group for all types of cancer. Response rates of 65 and 71% were achieved from the male and female control populations, respectively. Questionnaires, with telephone follow-up for clarification when necessary, were mailed to study subjects to obtain information on residential and occupational histories and other risk factors for cancer. The NECSS questionnaire included questions on smoking history, height, weight, physical activity, and education attainment. This research was approved by the ethics committee of Health Canada and written, informed consent was obtained from each study subject.

Dietary assessment. Food consumption data were obtained via a semiquantitative FFQ derived from 2 instruments developed in the United States that have been widely validated previously, i.e., the short Block questionnaire (13) and the Willett questionnaire (14). Subtle changes were made to the questionnaire items to take into account differences in American and Canadian dietary practices. The FFQ includes questions on 69 different food and beverage items, including the frequency of consumption and the amounts consumed. Participants were asked how often they had consumed these foods per week in the time period 2 y before interview. Food and beverage items were retrieved from the FFQ and used to estimate the daily intake of individual carotenoids, based on the USDA-Nutrition Coordinating Center (NCC) Carotenoid Database (15). This online database provides food composition values for 6 specific carotenoids contained in food and beverage items included in the study questionnaire. Information on other nutrients, including total carotenoids, dietary folate, and total energy, was obtained through the 1997 Canadian Nutrient File. Data were collected for 475 cases (264 men, 211 women) and 5039 controls (2547 men, 2492 women). We excluded controls _ 30 y of age (n _ 237) because pancreatic cancer cases are usually _30 y old. Furthermore, subjects with daily energy intake _ 500 kcal (2.092 MJ) (10 cases and 54 controls) or _ 5000 kcal (20.92 MJ) (3 cases and 27 controls) were excluded because such intakes are unrealistic and hence of questionable validity. Finally, a total of 462 cases (258 men, 204 women) and 4721 frequency-matched controls (2331 men, 2390 women) were eligible for analysis.

Statistical analysis. Food intake among cases and controls was analyzed according to carotenoid intake based on the USDA-NCC Carotenoid Database and the Canadian Nutrient File noted previously. Mean intakes were calculated separately for cases and controls. To compare the study population characteristics, we used the _2 test or Mantel extension test for categorical variables and the paired t test for continuous variables. To evaluate associations between carotenoids and pancreatic cancer risk, the study subjects were divided into 4 categories on the basis of quartiles of total and each specific energy-adjusted carotenoid intake in the control population. Odds ratios (ORs) and 95% CIs were calculated using unconditional logistic regression. Analyses were adjusted for matching variables (age group and province), lifetime cigarette consumption (0, _0-15, and _15 pack-y), BMI (_25, 25-29.9, and _30 kg/m2), educational attainment (y), dietary folate, and total energy intake. To evaluate the combined effect of intake of individual carotenoids and selected lifestyle variables (smoking, BMI, age, and educational attainment), the P-value for a multiplicative interaction term added to a fully adjusted model was examined; when it was significant, the analysis was stratified on that variable. Tests for linear trend in the carotenoid variables included in logistic regression were performed by replacing the indicator variables in each multivariate model with a single variable representing the median frequency of consumption for a given intake category, and by using the Wald _2 value computed for the regression coefficient of this variable to test the null hypothesis of no linear trend in pancreatic cancer risk across quartiles of intake. This analysis focused on carotenoid intake from diet, rather from specific carotenoid supplements. At the time the study was conducted, questions about the consumption of such supplements were not included in the FFQ. Models were fit for men and women separately. All tests of statistical significance were 2-sided and P-values _ 0.05 were considered significant. All analyses were conducted using SPSS statistical software (release 10.02, SPSS).

RESULTS Selected characteristics of the study population are presented (Table 1). In both men and women, there were appreciable differences between cases and controls for age distributions with an excess of younger control subjects (P _ 0.05); in addition, cases were more likely to use high amounts of tobacco (P _ 0.01). Two years before the diagnosis of cancer, there was a higher pancreatic cancer risk with increased BMI in both genders (P _ 0.05). Among men, cases were more likely to have greater total energy intake than controls (P _ 0.01). The main food sources of _-carotene in the diet were carrots and tomatoes. _-Carotene was derived primarily from potatoes, carrots, and spinach. _-Cryptoxanthin was supplied by oranges and fruit juices, whereas lycopene was mainly from tomatoes, tomato juice, and tomato sauce. Lutein _ zeaxanthin were from broccoli and green-leaf vegetables, and total carotenoids were mainly from potatoes, carrots, and cantaloupes. The ORs and corresponding 95% CIs for pancreatic cancer according to specific and total carotenoid intakes are summarized (Table 2). After adjustment for age, province, educational attainment, smoking, BMI, folate, and total energy DIETARY CAROTENOIDS AND PANCREATIC CANCER RISK 593 intake, a significant inverse association was observed between pancreatic cancer risk and lycopene intake in men (OR _ 0.69; 95% CI: 0.46-0.96; P _ 0.026 for trend), when comparing the highest quartile of intake with the lowest. Intakes of _-carotene, _-carotene, _-cryptoxanthin, lutein/ zeaxanthin, and total carotenoids were not associated with pancreatic cancer risk. There was evidence of an interaction between tobacco use and _-carotene (P _ 0.02) as well as total carotenoids (P _ 0.013). The risk of pancreatic cancer in relation to intake of carotenoids is presented by level of tobacco consumption (Table 3). Among those who never smoked, inverse doseresponse relations were apparent between _-carotene (OR _ 0.57; 95% CI: 0.32- 0.99; P _ 0.016 for trend) and total carotenoids (OR _ 0.58; 95% CI: 0.34 -1.00; P _ 0.02 for trend) and pancreatic cancer, when comparing the highest with the lowest quartile of intakes. These results did not differ among subgroups defined by pack-years of cigarette smoking. Overall, there was no significant effect modification by BMI, age, physical activity, and educational attainment (data not shown).

DISCUSSION This population-based case-control study demonstrated an inverse dose-response relation between lycopene and pancreatic cancer in men. Intakes of _-carotene and total carotenoids were significantly associated with reduced pancreatic cancer risk among those who never smoked. To the best of our knowledge, this is the first epidemiologic study to examine the role of specific dietary carotenoids in risk assessment of pancreatic cancer.

Previous observational investigations assessed the relation between lycopene serum concentrations and pancreatic cancer with consistent results. A case-control study found that plasma lycopene levels were significantly lower in pancreatic cancer cases than in matched controls (16). In the Washington County Cohort Study, in which subjects were followed for almost 15 y, significantly lower baseline serum lycopene levels were documented in subjects with pancreatic cancer than in matched cohort controls (17,18). Lower serum lycopene levels were observed in individuals with certain chronic diseases, including cancer, suggesting that lycopene intake reduces the occurrence, extent, or degree of these conditions, or that lycopene is depleted by oxidative stress and inflammatory processes (19). Interestingly, in vitro studies suggest that lycopene inhibits gap junction communication (20), activates phase II enzymes (21), suppresses eicosanoid metabolism by blocking cyclooxygenase-2 synthesis (22), and inhibits tumor cell growth by repressing insulin-like growth factor 1 receptor activation (23). However, these putative mechanisms remain speculative and require confirmation. We observed a 42% reduction in pancreatic risk in relation to both _-carotene and total carotenoids among those who never smoked, but no clear evidence of an association between any individual or total carotenoid intakes and pancreatic cancer risk among past or current smokers. Exposure to tobacco smoke causes extensive _-carotene oxidation (24). It was reported that cigarette smoking is independently associated with lowered circulating concentrations of provitamin A carotenoids: in general, active smokers have _25% lower circulating concentrations of _-carotene, _-carotene, and _-cryptoxanthin than nonsmokers, even after adjusting for dietary

TABLE 1 Selected characteristics of the study population1 Men (n _ 2589) Women (n _ 2594) Cases (n _ 258) Controls (n _ 2331) Cases (n _ 204) Controls (n _ 2390) n (%) Age, y 30-34 2 (1)* 124 (5.5) 3 (1.5)† 62 (3) 35-39 6 (2)* 140 (6) 2 (1)† 124 (5) 40-44 6 (2)* 109 (4.5) 12 (6)† 224 (9) 45-49 15 (6)* 113 (5) 13 (6.5)† 335 (14) 50-54 27 (11)* 152 (7) 21 (10)† 274 (11) 55-59 33 (13)* 217 (9) 25 (12)† 269 (11) 60-64 52 (20)* 350 (15) 33 (16)† 351 (15) 65-69 62 (24)* 537 (23) 53 (26)† 377 (16) 70-74 55 (21)* 589 (25) 42 (21)† 374 (16) Cigarette consumption, pack-y 0 57 (22)† 571 (25) 87 (43)† 1196 (50) _0-15 48 (19)† 706 (30) 45 (22)† 678 (28) _15 150 (58)† 1026 (44) 69 (34)† 491 (21) Missing 3 (1) 28 (1) 3 (1) 25 (1) BMI 2 y before diagnosis,kg/m2 _25 86 (33)* 882 (38) 102 (50)† 1353 (57) 25-29.9 118 (46)* 1099 (47) 55 (27)† 717 (30) _30 54 (21)* 350 (15) 47 (23)† 320 (13) Physical activity,2 h/mo _21 75 (29) 563 (24) 59 (29) 605 (25) 21-23 120 (47) 1207 (52) 108 (53) 1343 (56) _23 62 (24) 561 (24) 37 (18) 442 (19) Daily energy intake, kJ/d 8268 _ 3511† 7549 _ 2822 7265 _ 2541 6859 _ 2491 1 Values are means _ SD or n (%). Symbols indicate different from controls: * P _ 0.05; † P _ 0.01. 2 Defined as total number of hours per month of moderate and vigorous activities.

594 NKONDJOCK ET AL. intake and other demographic factors (10,25). Moreover, depressed plasma _-carotene concentrations were reported in response to enhanced metabolic turnover resulting from smoking- induced oxidative stress (26). If this putative oxidative mechanism can be shown to affect the relation between _-carotene and smoking, it would help explain why _-carotene and total carotenoids, which come from similar sources, were associated with a reduced pancreatic cancer risk in this study only among those who never smoked. The major strengths of our study include its uniqueness, the large number of pancreatic cancer cases, histological diagnosis of pancreatic cancer cases, and general population sampling. Ours is the first study to examine the role of dietary carotenoid intakes in risk assessment of pancreatic cancer. The large sample size permitted subgroup analyses by sex and smoking status. Histological confirmation of diagnosis reduced the possibility of disease misclassification, whereas the populationbased approach to subject selection facilitated extrapolation of our results to the general population. Our study is also subject to certain limitations. Because the assessment of dietary exposure was retrospective, recall bias cannot be completely excluded. A prospective cohort ap-

TABLE 2 Odds ratio (OR) and 95% CI for pancreatic cancer associated with dietary carotenoids1,2 Carotenoid Gender Quartiles of energy-adjusted carotenoid intakes P for 1 2 3 4 trend _-Carotene Male Dietary intake, _g/d 358 _ 212 694 _ 284 1051 _ 214 2060 _ 1044 Cases/Controls, n 68/696 77/549 58/516 45/501 Multivariate OR (95% CI) 1.00 0.68 (0.46-0.98) 0.80 (0.54-1.19) 1.01 (0.67-1.53) 0.90 Female Dietary intake, _g/d 341 _ 182 651 _ 270 1013 _ 200 2059 _ 1147 Cases/Controls, n45/443 42/590 58/623 51/638 Multivariate OR (95% CI) 1.00 1.65 (1.04-2.61) 1.31 (0.84-2.04) 1.56 (0.98-2.42) 0.13 _-Carotene Male Dietary intake, _g/d 6215 _ 3832 10,621 _ 3522 15,788 _ 3173 25,763 _ 14,196 Cases/Controls, n 69/634 64/532 69/565 46/531 Multivariate OR (95% CI) 1.00 0.93 (0.63-1.38) 0.89 (0.61-1.30) 1.22 (0.80-1.87) 0.58 Female Dietary intake, _g/d 5953 _ 3387 9803 _ 2882 14,935 _ 3269 22,059 _ 10,683 Cases/Controls, n 40/505 39/607 61/574 56/608 Multivariate OR (95% CI) 1.00 1.30 (0.80-2.12) 0.83 (0.53-1.30) 0.96 (0.60-1.51) 0.40 P-Cryptoxanthin Male Dietary intake, _g/d 77 _ 66 162 _ 83 267 _ 80 598 _ 314 Cases/Controls, n 75/676 77/565 51/524 45/497 Multivariate OR (95% CI) 1.00 0.73 (0.51-1.05) 1.02 (0.68-1.53) 1.09 (0.72-1.62) 0.46 Female Dietary intake, _g/d 837 _ 716 1139 _ 753 1951 _ 820 7234 _ 6510 Cases/Controls, n 52/462 37/575 52/615 55/642 Multivariate OR (95% CI) 1.00 1.50 (0.95-2.38) 1.26 (0.82-1.94) 1.23 (0.80-1.87) 0.27 Lycopene Male Dietary intake, _g/d 898 _ 772 1215 _ 859 2106 _ 917 7585 _ 6505 Cases/Controls, n 56/651 58/536 63/518 71/557 Multivariate OR (95% CI) 1.00 0.78 (0.51-1.19) 0.76 (0.49-1.16) 0.69 (0.46-0.96) 0.026 Female Dietary intake, _g/d 837 _ 716 1139 _ 753 1951 _ 820 7234 _ 6510 Cases/Controls, n 42/487 41/604 48/621 65/582 Multivariate OR (95% CI) 1.00 1.38 (0.84-2.56) 1.05 (0.65-1.70) 0.91 (0.56-1.43) 0.27 Lutein _ Zeaxanthin Male Dietary intake, _g/d 767 _ 380 1105 _ 382 1702 _ 499 3574 _ 1585 Cases/Controls, n 85/704 53/594 61/516 49/448 Multivariate OR (95% CI) 1.00 1.19 (0.81-1.74) 0.99 (0.68-1.44) 1.13 (0.76-1.68) 0.63 Female Dietary intake, _g/d 752 _ 368 1057 _ 348 1576 _ 418 3690 _ 1694 Cases/Controls, n 42/435 41/546 57/622 56/691 Multivariate OR (95% CI) 1.00 1.09 (0.68-1.75) 1.12 (0.70-1.78) 1.25 (0.79-1.98) 0.23 Total carotenoids Male Dietary intake,3 RE/d 1514 _ 955 2578 _ 851 3813 _ 729 6365 _ 3359 Cases/Controls, n71/645 66/532 62/542 49/543 Multivariate OR (95% CI) 1.00 0.92 (0.62-1.36) 0.84 (0.58-1.23) 1.22 (0.80-1.86) 0.68 Female Dietary intake, RE/d 1448 _ 848 2444 _ 696 3629 _ 759 5551 _ 2642 Cases/Controls, n 42/494 4 0/608 56/596 58/596 Multivariate OR (95% CI) 1.00 1.11 (0.69-1.78) 0.92 (0.58-1.44) 0.91 (0.58-1.44) 0.50 1 Values are means _ SD or OR (95% CI). 2 OR and 95% CI from the logistic regression model adjusted for age, province, smoking, educational attainment, BMI, folate, and total energy intake.

3 Defined as retinol equivalent. DIETARY CAROTENOIDS AND PANCREATIC CANCER RISK 595 proach has several advantages when studying associations between nutritional factors and cancer risk. However, because of the relatively low incidence of pancreatic cancer, the largest cohort to date examining diet and pancreatic cancer risk included only 178 pancreatic cancer cases throughout 18 y of follow-up (27). We could not adjust OR estimates for the potentially confounding effect of diabetes mellitus and family history of pancreatic cancer because this information was not collected at baseline. Nevertheless, we expect that diabetes did not confound the association between dietary carotenoids and pancreatic cancer risk because diet is likely to be an initial risk factor for both chronic diseases, rather than lying on their causal pathways. In addition, it was suggested that the importance of diabetes is much reduced if pancreatic cancer cases of recent onset are excluded (28). In addition, it is unlikely that the confounding effect of family aggregation of pancreatic cancer may explain the associations we found because genetic/ familial predisposition is relatively rare (29). Moreover, confirmation of a hereditary component is particularly challenging because pancreatic cancer may occur only infrequently in some of the hereditary cancer syndromes, in accordance with reduced frequency of the deleterious, predisposing mutations (30). Although the USDA-NCC Carotenoid Database used in the present analysis represents the most current and comprehensive data available to date, data were not available for all of the Canadian food items we investigated. In addition, the carotenoid content of foods is highly variable depending on a number of factors, including geographical area and growing conditions, cultivar or variety, processing techniques, method of food preparation, and length and conditions of storage (4). As a consequence, the likelihood of nondifferential misclassification cannot be completely excluded, raising the possibility that some associations were obscured. Another limitation is the consequence of early and high case fatality associated with the disease. As in other epidemiologic studies of pancreatic cancer, cases who died before the questionnaire could be administered were not included in the analysis. Bias may have been introduced in the present investigation if rapidly fatal cases had a different etiology from cases with longer survival, or if the dietary carotenoids under study influenced survival. However, because there was no discrimination in the selection of study subjects based on their demographic characteristics and lifestyle factors, such as age, dietary patterns, smoking, or educational attainment, survivors are still representative of the study population. Consequently, selection bias is unlikely to be substantial. In conclusion, we found a significantly reduced pancreatic cancer risk with dietary intake of lycopene among men. A significant inverse association was also observed between pancreatic cancer risk and both dietary _-carotene and total carotenoid intakes among those who never smoked. As a whole, our data supported the association of a diet rich in vegetables with a reduction in risk of pancreatic cancer. More studies assessing associations between dietary carotenoids and the risk of pancreatic cancer are warranted to better elucidate the role of diet in the etiology of pancreatic cancer.

ACKNOWLEDGMENTS The Canadian Cancer Registries Epidemiology Research Group comprises a Principal Investigator from each of the Provincial Cancer Registries: B. Paulse, Newfoundland Cancer Foundation; R. Dewar, Nova Scotia Cancer Registry; D. Dryer, Prince Edward Island Cancer Registry; N. Kreiger, Cancer Care Ontario; E. Kliewer, Cancer Care Manitoba; D. Robson. Saskatchewan Cancer Foundation; S. Fincham, Division of Epidemiology, Prevention and Screening, Alberta Cancer Board; and N. Le, British Columbia Cancer Agency.

LITERATURE CITED 1. Canadian Cancer Society. Available at: http://www.cancer.ca [Accessed October 22, 2004]. 2. Surveillance, Epidemiology, and End Results Program (1997) Seer Cancer Statistics Review, 1973-1994: Tables and Graphs. National Cancer Institute, Bethesda, MD. 3. Yeo, C. J. & Cameron, J. L. (1999) Pancreatic cancer. Curr. Probl. Surg. 36: 59-152. 4. Khachik, F., Askin, F. B. & Lai, K. (1998) Distribution, bioavailability, and metabolism of carotenoids in humans. In: Phytochemicals: A New Paradigm (Bidlack, W. R., Omaye, S. T., Meskin, M. S. & Jahner, D., eds.). Technimin Publishing, Lancaster, PA. 5. Zhang, L. X., Cooney, R. V. & Bertram, J. S. (1991) Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/ 10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 12: 2109-2114. 6. Cooper, D. A., Eldridge, A. L. & Peters, J. C. (1999) Dietary carotenoids and certain cancers, heart disease, and age-related macular degeneration: a review of recent research. Nutr. Rev. 57: 201-214. 7. Palozza, P., Serini, S., Torsello, A., Di Nicuolo, F., Piccioni, E., Ubaldi, V., Pioli, C., Wolf, F. I. & Calviello, G. (2003) _-Carotene regulates NF-_B DNA binding activity by a redox mechanism in human leukemia and colon adenocarcinoma cells. J. Nutr. 133: 381-388. 8. Herber, D. & Lu, Q. Y. (2002) Overview of mechanism of action of lycopene. Exp. Biol. Med. 227: 920-923.

TABLE 3 Odds ratio (OR) and 95% CI for pancreatic cancer associated with dietary carotenoids and tobacco use1,2 Tobacco use Carotenoid Quartiles of energy-adjusted carotenoid intakes P for 1 2 3 4 trend Never smoked _-Carotene 1.00 1.09 (0.60-1.99) 0.72 (0.41-1.28) 0.57 (0.32-0.99) 0.016
Cases/Controls, n 27/467 27/470 39/432 48/441
Total carotenoids 1.00 1.10 (0.61-2.00) 0.79 (0.45-1.38) 0.58 (0.34-1.00) 0.020
Cases/Controls, n 28/470 28/463 36/433 49/444
Past smokers _-carotene 1.00 1.24 (0.78-1.97) 0.98 (0.64-1.51) 1.38 (0.86-2.22) 0.44
Cases/Controls, n 50/425 40/451 59/502 40/486
Total carotenoids 1.00 1.07 (0.68-1.70) 0.94 (0.61-1.47) 1.22 (0.76-1.97) 0.62
Cases/Controls, n 49/418 43/458 57/504 41/486
Current smokers _-Carotene 1.00 0.83 (0.47-1.46) 0.82 (0.47-1.44) 1.61 (0.85-3.04) 0.24
Cases/Controls, n 32/285 36/260 39/248 25/254
Total carotenoids 1.00 0.76 (0.44-1.34) 0.85 (0.49-1.49) 1.70 (0.90-3.23) 0.15
Cases/Controls, n 33/291 37/262 37/246 24/250
1 Values are OR (95% CI).
2 OR and 95% CI from the logistic regression model adjusted for age, sex, province, educational attainment, BMI, folate, and total energy intake. 596 NKONDJOCK ET AL.
9. Nishino, H., Tokuda, H., Murakoshi, M., Satomi, Y., Masuda, M., Onozuka, M., Yamaguchi, S., Takayasu, J., Tsuruta, J., Okuda, M., Khachik, F., Narisawa, T., Takasuka, N. & Yano, M. (2000) Cancer prevention by natural carotenoids. Biofactors 13: 89-94.
10. Alberg, A. J. (2002) The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 180: 121-137.
11. Villeneuve, P. J., Johnson, K. C., Hanley, A. J. & Mao, Y. (2000) Alcohol, tobacco and coffee consumption and the risk of pancreatic cancer: results from the Canadian Enhanced Surveillance System case-control project. Canadian Cancer Registries Epidemiology Research Group. Eur. J. Cancer Prev. 9: 49-58.
12. World Health Organization (1985) International Classification of Diseases, 9th rev. WHO, Geneva, Switzerland.
13. Block, G., Hartman, A. M. & Naughton, D. (1990) A reduced dietary questionnaire: development and validation. Epidemiology 1: 58-64.
14. Willett, W., ed. (1998) Nutritional Epidemiology, 2nd ed. Oxford University Press, New York, NY.
15. The US Department of Agriculture and the Nutrition Coordinating Center (2004) Available at: http://www.nal.usda.gov/fnic/foodcomp/Data/SR17/ [Assessed October 13, 2004].
16. Abiaka, C. D., Al-Awadi, F. M., Al-Sayer, H., Gulshan, S., Behbehani, A. & Farghaly, M. (2001) Plasma micronutrient antioxidants in cancer patients. Cancer Detec. Prev. 25: 245-253.
17. Burney, P. G., Comstock, G. W. & Morris, J. S. (1989) Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer. Am. J. Clin. Nutr. 49: 895-900.
18. Comstock, G. W., Helzlsouer, K. J. & Bush, T. L. (1991) Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am. J. Clin. Nutr. 53 (suppl. 1): 260S-264S.
19. Gerster, H. (1997) The potential role of lycopene for human health. J. Am. Coll. Nutr. 16: 109-126.
20. Stahl, W., von Laar, J., Martin, H. D., Emmerich, T. & Sies, H. (2000) Stimulation of gap junctional communication: comparison of acyclo-retinoic acid and lycopene. Arch. Biochem. Biophys. 373: 271-274.
21. Breinholt, V., Lauridsen, S. T., Daneshvar, B. & Jakobsen, J. (2000) Dose-response effects of lycopene on selected drug-metabolizing and antioxidant enzymes in the rat. Cancer Lett. 154: 201-210.
22. Cacciola, S. A., Cohen, L. A. & Kashfi, K. (1999) Lycopene inhibits proliferation and regulates cyclooxygenase-2 gene expression in neoplastic rat mammary epithelial cells. FASEB J. 13: 441 (abs.).
23. Karas, M., Amir, H., Fishman, D., Danilenko, M., Segal, S., Nahum, A., Koifmann, A., Giat, Y., Levy, J. & Sharoni, Y. (2000) Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr. Cancer. 36: 101-112.
24. Arora, A., Willhite, C. A. & Liebler, D. (2001) Interactions of _-carotene and cigarette smoke in human bronchial epithelial cells. Carcinogenesis 22: 1173-1178.
25. Dietrich, M., Block, G., Norkus, E. P., Hudes, M., Traber, M. G., Cross, C. E. & Packer, L. (2003) Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am. J. Clin. Nutr. 77: 160- 166.
26. Marangon, K., Herbert, B., Lecomte, E., Paul-Dauphin, A., Grolier, P., Chancerelle, Y., Artur, Y. & Siest, G. (1998) Diet, antioxidant status, and smoking habits in French men. Am. J. Clin. Nutr. 67: 231-239.
27. Michaud, D. S., Giovannucci, E., Willett, W. C., Colditz, G. A. & Fuchs, C. S. (2003) Dietary meat, dairy products, fat, and cholesterol and pancreatic cancer risk in a prospective study. Am. J. Epidemiol. 157: 1115-1125.
28. World Health Organization, International Agency for Research on Cancer (2003) In: World Cancer Report (Steward, B.W. & Kleihues, P., eds.). IARC Press, Lyon, France.
29. Ghadirian, P., Boyle, P., Simard, A., Baillargeon, Maisonneuve, P. & Perret, C. (1991) Reported family aggregation of pancreatic cancer with a population-based case-control study in the Francophone community in Montreal, Canada. Int. J. Pancreatol. 10: 183-196.
30. Ghadirian, P., Lynch, H. T. & Krewski, D. (2003) Epidemiology of pancreatic cancer: an overview. Cancer Detect. Prev. 27: 87-93. DIETARY CAROTENOIDS AND PANCREATIC CANCER RISK 597